Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 21 ... recent FDA neurology advisory committee recommended approval of Ioflupane I-123, a SPECT radiopharmaceutical for imaging dopaminergic degeneration. AV-133 will utilize the higher resolution PET ...
2009 AUG 17 ... operates a network of nearly 160 nuclear pharmacies and operates 26 cyclotron-based PET radiopharmaceutical manufacturing facilities. These facilities are registered with the Food and Drug ...
2009 SEP 21 ... For additional information, contact M. Honer, ETH, Center Radiopharmaceutical Science, Animal Imaging Center PET, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland. ...
2009 AUG 24 ... identified for areas of unmet medical need. If approved, DaTSCAN will be the first radiopharmaceutical agent available to detect DaT distribution within the brain. "We are ...
2009 NOV 9 ... Mathew Thakur Ph.D. Professor of Radiology and Director of the Laboratories of Radiopharmaceutical Research and Molecular Imaging at Thomas Jefferson University Hospital says, "The use ...
2009 NOV 27 ... recent research published in the Journal of Radioanalytical and Nuclear Chemistry, "The radiopharmaceutical [Sm-153]Sm-EDTMP is administered for painful bone metastases with the standard dosage of ...
2009 SEP 14 ... acid-bis (amide) conjugates have been synthesized and evaluated as a potential radiopharmaceutical for tumor imaging. The compounds were synthesized by the condensation reaction of DTPA ...
2009 NOV 23 ... who had SLNB after prior neoadjuvant chemotherapy was performed. A combination of radiopharmaceutical 99mTc-albumin colloid (Pharmalucence, MA, USA) and Patent Blue V dye (Guerbet, France) ...
2009 OCT 5 ... For additional information, contact S. Banerjee, Bhabha Atom Research Center, Radiopharmaceutical Chemical Sect, Radiopharmaceutical Division, Mumbai ...
2009 NOV 1 ... and nonhypoxic tissues. The safety and general biodistribution patterns of this radiopharmaceutical in patients with squamous cell carcinoma of the head and neck (HNSCC), small-cell lung ...
2009 SEP 8 ... For additional information, contact S. Forsback, Turku PET Center, Radiopharmaceutical Chemical Laboratory, Porthaninkatu 3, FI-20500 Turku, Finland. Publisher ...
2009 NOV 25 ... the United States, "Imaging beta rays in vivo will help to advance micro-dosimetry and radiopharmaceutical development. In an earlier paper [1], we reported a newly developed system capable of ...
2009 NOV 16 ... and nonhypoxic tissues. The safety and general biodistribution patterns of this radiopharmaceutical in patients with squamous cell carcinoma of the head and neck (HNSCC), small-cell lung ...
2009 SEP 8 ... For additional information, contact A. Dash, Bhabha Atom Research Center, Radiopharmaceutical Division, Bombay 400085, Maharashtra, India. Publisher contact information ...
2009 NOV 1 ... Dr. Buckley was instrumental in the development of the first centrally manufactured radiopharmaceutical-Iodine-131 antibody (Bexxar™). He holds a Ph.D. in immunology from the UMDNJ ...
2009 NOV 2 ... provides very specific evidence about the benefits of local therapy with 131I-TM601 radiopharmaceutical used in cases where prior therapies have failed. Additionally, the study complements ...
2009 AUG 24 ... research from the United States, "Samarium-153 (Sm-153) lexidronam is a bone-targeting radiopharmaceutical with a short physical half-life and a favorable toxicity profile. We evaluated the ...
